Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreBringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreYour world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreFor government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MOREToday, the healthcare environment is more specialized, competitive, and cost-sensitive than ever before. Life sciences product teams need the right evidence to determine, demonstrate, and communicate the value of their products (e.g., drugs, devices, diagnostics) across the product lifecycle, and to inform complex healthcare decisions.
Ivo Abraham, Ph.D.
Editor-in-Chief, Journal of Medical Economics
Chi-Chang Chen, Ph.D., MsPharm
Sr. Principal, U.S. Medical and Scientific Services, IQVIA
Mickaël Hiligsmann, Ph.D.
Editor-in-Chief, Expert Review of Pharmacoeconomics & Outcomes Research
Aimee Near, MPH
Sr. Principal, U.S. Medical and Scientific Services, IQVIA
Meet your clinical, economic, and regulatory needs throughout a product's lifecycle